Introduction to pharmacology
Summary
TLDRThis script explores the complex journey of drug development, from discovery to clinical trials, emphasizing the importance of safety, efficacy, and therapeutic index. It delves into pharmacokinetics and pharmacodynamics, highlighting how medications interact with the body and the potential for drug interactions, crucial for clinicians to understand.
Takeaways
- 💊 Pharmacology is the study of how medications interact with living systems, from molecules to whole organisms, to produce effects.
- 🔍 Developing a new medication involves three main steps: Discovery, Pre-clinical research, and Clinical development.
- 🔬 Discovery is when a potential therapeutic compound is identified for a specific disease.
- 🐁 Pre-clinical research tests the compound on cell cultures and animals to assess safety.
- 🏥 Clinical development includes clinical trials on humans, conducted in four phases to evaluate safety, efficacy, and real-life application.
- 🧪 Phase 1 trials assess safety in a small group of healthy individuals.
- 🔍 Phase 2 trials determine the medication's effectiveness in a moderate group of affected individuals.
- 🏥 Phase 3 trials compare the new medication to standard treatment in a larger group to evaluate superiority or equivalence.
- 🏛️ Regulatory approval is based on the results of Phase 3 trials, which simulate real-life medication administration.
- 💡 A new medication can have three names: a chemical name, a generic name, and one or more brand names.
- 🌐 After approval, Phase 4 involves post-market surveillance for long-term or rare side effects.
- 💉 Pharmacokinetics studies how the body processes a medication (absorption, distribution, metabolism, and excretion).
- 🔬 Pharmacodynamics studies the effects a medication has on the body, including both therapeutic and side effects.
- 🚑 Medications with a low therapeutic index have a narrow margin of safety and require close monitoring.
- 🤝 Drug interactions can occur at both pharmacokinetic and pharmacodynamic levels, affecting how medications are absorbed, metabolized, and interact with each other.
Q & A
What is pharmacology?
-Pharmacology is the study of medications or chemical compounds that interact with living systems, from molecules to whole organisms, to produce a certain effect. It involves understanding how these substances are used to treat diseases.
What are the three main steps in the development of a new medication?
-The three main steps in the development of a new medication are discovery, pre-clinical research, and clinical development. Discovery involves identifying a potential therapeutic compound, pre-clinical research tests the compound on cell cultures and animals, and clinical development includes clinical trials on humans.
What is the purpose of pre-clinical research in drug development?
-Pre-clinical research is conducted to test the candidate compound on cell cultures and animals, primarily to determine if it causes any serious harm to living organisms. This step is crucial for understanding the safety profile of the compound before it is tested on humans.
What are the four phases of clinical trials for a new medication?
-The four phases of clinical trials are: Phase 1, which tests the medication in a small group of healthy individuals for safety; Phase 2, which assesses the medication's effectiveness and optimal dosage in a moderately sized group of affected individuals; Phase 3, which compares the new medication to standard treatment in a larger group to determine its efficacy; and Phase 4, which is a post-marketing surveillance phase to monitor long-term safety and detect rare side effects.
What does the acronym 'SEAL' stand for in the context of clinical trials?
-In the context of clinical trials, 'SEAL' stands for Safety, Efficacy, Approval, and Long-term phase, which are the key aspects that need to be addressed to ensure a medication is safe and effective for use.
Why are there three names for a medication?
-A medication has three names to describe different aspects of its identity: a chemical name that describes its chemical structure (e.g., N-Acetal P Amino phenol), a generic name that is a shortened version used by health professionals (e.g., paracetamol or acetaminophen), and one or more brand or trade names given by pharmaceutical companies (e.g., Panadol or Tylenol).
What is pharmacokinetics and what does it involve?
-Pharmacokinetics refers to the movement and modification of a medication within the body. It involves the absorption of the medication into the circulation, its distribution to various tissues, metabolism or breakdown, and finally, its elimination from the body, typically through urine or feces.
What is pharmacodynamics and how does it differ from pharmacokinetics?
-Pharmacodynamics refers to the effects that a medication has on the body. It involves how the medication interacts with receptors or proteins in the body, leading to changes in cellular function. This is different from pharmacokinetics, which focuses on how the body processes the medication.
What is the therapeutic index and why is it important?
-The therapeutic index is the ratio between the toxic dose (TD50) and the effective dose (ED50) of a medication. It indicates the safety margin of a drug, with a larger index indicating a safer medication. Medications with a low therapeutic index require close monitoring to prevent toxicity.
How can medications interact with each other, and what are the potential effects?
-Medications can interact with each other at both pharmacokinetic and pharmacodynamic levels. Pharmacokinetic interactions occur when one medication alters the absorption, distribution, metabolism, or excretion of another. Pharmacodynamic interactions occur when medications directly influence each other's effects, potentially leading to synergistic or antagonistic effects.
Outlines
💊 Understanding Medication Development and Interaction
This paragraph delves into the intricate world of pharmacology, focusing on the development of new medications. It outlines the three main steps involved: Discovery, where a potential therapeutic compound is identified; Pre-clinical research, involving testing on cell cultures and animals to assess safety; and Clinical development, encompassing clinical trials in four phases to evaluate safety and efficacy. The paragraph also touches on the naming conventions for medications, including chemical, generic, and brand names. Additionally, it highlights the importance of pharmacokinetics and pharmacodynamics in understanding how medications interact with the body, and the concept of the therapeutic index, which measures the safety of a medication by comparing its toxic and effective doses.
🔍 Exploring Drug Interactions and Safety Margins
The second paragraph expands on the complexities of drug interactions and the safety considerations in medication use. It discusses the therapeutic index, emphasizing its role in determining the safety of a drug by comparing the median toxic dose to the median effective dose. Medications with a low therapeutic index are highlighted as needing close monitoring due to their narrow margin of safety. The paragraph also explores pharmacokinetic and pharmacodynamic interactions, explaining how drugs can influence each other's effects, either through competition for metabolic enzymes or by directly affecting each other's actions. The potential for synergistic or antagonistic effects between medications is also discussed, illustrating the importance of understanding these interactions to ensure safe and effective treatment.
Mindmap
Keywords
💡Pharmacology
💡Medications
💡Discovery
💡Pre-clinical research
💡Clinical trials
💡Pharmacokinetics
💡Pharmacodynamics
💡Therapeutic index
💡Generic name
💡Brand name
💡Drug interactions
Highlights
Pharmacology is the study of medications and their interactions with living systems.
New medications are designed to fight diseases such as infections, cancer, heart failure, and depression.
Developing a new medication is a lengthy and costly process.
The drug development process consists of three main steps: Discovery, Pre-clinical research, and Clinical development.
Discovery involves selecting a candidate compound as a potential therapeutic agent.
Pre-clinical research tests the compound on cell cultures and animals to assess safety.
Clinical development involves testing the compound on humans through clinical trials.
Clinical trials are conducted in four phases, each with a specific purpose.
Phase one trials test the medication's safety in a small group of healthy individuals.
Phase two trials determine the medication's effectiveness and optimal dosage.
Phase three trials compare the new medication to standard treatment to assess its efficacy.
Phase four is a post-market surveillance phase that monitors for long-term or rare side effects.
A new medication will have a chemical name, a generic name, and one or more brand names.
Drug administration involves pharmacokinetics, which studies the movement and modification of the medication in the body.
Pharmacodynamics studies the effects of the medication on the body, including beneficial and side effects.
The therapeutic index measures the safety of a medication by comparing the toxic dose to the effective dose.
Medications with a low therapeutic index require close monitoring to prevent toxicity.
Drug interactions can occur at both pharmacokinetic and pharmacodynamic levels.
Pharmacokinetic interactions involve one medication altering the absorption, distribution, metabolism, or excretion of another.
Pharmacodynamic interactions occur when medications directly influence each other's effects.
Transcripts
pharmacology is the study of medications
or chemical compounds which interact
with various living systems from Tiny
molecules to cells to tissues and whole
organisms in order to produce a certain
effect every day more and more new
medications are designed to fight
diseases from infections to cancer heart
failure and depression but the process
of developing a new medication can take
a lot of time and money and it typically
consists of Three Steps step one is
Discovery and that's when a candidate
compound is picked out as a possible
therapeutic agent for a specific disease
step two is pre-clinical research during
which this compound is tested on Cell
cultures and animals like mice and rats
mainly to see if it causes any serious
harm on living organisms and finally
step three is clinical development
during which clinical trials are
performed that's where the compound is
tested on humans to see if if it's safe
and effective in treating
diseases for a new medication clinical
trials are done in four phases which can
be remembered with the pneumonic all
medications need the seal of approval
which stands for safety efficacy
approval and longterm phase one trials
test the medication in a small group of
healthy individuals to see if it's safe
for
humans Phase 2 trials aim to find out
more about how effective the medication
is or how well it works at a certain
dose this is done by testing it on a
moderately sized group of individuals
affected by the condition in
question in phase three trials the new
medication is compared to the standard
treatment to find out if it's actually
just as good as or even better than the
existing one phase 3 trials generally
involve a much larger number of
individuals and aim to replicate the
exact setting in which the medication
will be administered in real life which
will then be used used as the basis for
approval by regulatory organizations for
the
market the whole process can take up to
10 years or more depending on the
compound but if all this goes well
congratulations we've got a new
medication now that new medication will
have at least three names a chemical one
describing its chemical structure and
used mostly in scientific studies like n
acetal P Amino phenol a generic name
which which is usually a shortened
version of the chemical name and is
mostly used by health professionals such
as paracetamol or acetaminophen and one
or more brand or trade names given by
the pharmaceutical companies that make
the medication such as Panadol or
Tylenol okay but the Journey of drug
development hasn't finished quite yet
once a medication reaches the
marketplace there's phase four which is
a final phase of safety surveillance
that looks for long-term or rare side
effects that might have been missed if
it's found to be unsafe a recall and ban
might be
needed all right now once a medication
is administered it starts interacting
with the body this interaction can be
broken down into pharmacokinetics and
pharmacodynamics pharmacokinetics refers
to the movement and modification of the
medication inside the body in other
words it's what the body does to this
medication so once the medication gets
administered it first has to absorbed
into the circulation then distributed to
various tissues throughout the body
metabolized or broken down and finally
eliminated or excreted in the urine or
feces you can remember this as adme
absorption distribution metabolism and
excretion pharmacodynamics on the other
hand refers to what the medication does
to the body so once again after the
administration of a medication it binds
to receptors or specialized proteins
located on the surface of or inside a
cell this gives rise to a signal Cascade
which ultimately results in some change
in the cell's function like boosting the
production of a particular type of
protein or slowing down DNA replication
an ideal medication would produce a
single beneficial or therapeutic effect
for a certain disease state in reality
though most medications produce several
unwanted effects called side effects
like nausea or
fatigue now in order to deter the safety
of a medication we can look at its
therapeutic index the therapeutic index
refers to the ratio between the toxic
dose and effective dose of a given
medication we can illustrate this using
a nice graph that shows the relationship
between the amount of a medication given
also known as dose on the x-axis usually
on a logarithmic scale with the response
produced on the y- AIS what we get is an
s-shaped curve called dose response
curve so to calculate the therapeutic
index we divide the median toxic dose or
td50 which is the dose that causes a
toxic response in 50% of the population
by the median effective dose or ed50
which is the dose that produces a
clinically desired effect in 50% of the
population the closer the ratio is to
one the higher the danger of toxicity so
the larger the therapeutic index the
safer a medication is considered to
be all right medications that have a low
therapeutic index have a narrow margin
of safety which means that there is a
thin line between the dose needed to
produce the desired effect and the toxic
dose so these medications including
warin lithium dexin gentamycin phenin or
theophine require close monitoring of
serum
levels finally let's talk about what
happens when two or more medications are
administered together first of all there
are a whole bunch of ways medications
can interact with each other both at
pharmacokinetic and pharmacodynamic
levels pharmacokinetic interactions
occur when one medication Alters the
absorption distribution metabolism or
excretion of another thereby changing
the amount of medication available to
produce the desired effect for example
in pharmacokinetics it might be that two
medications are metabolized by the same
enzymes so they compete for the same
enzyme sites on the other hand
pharmacodynamic interactions occur when
medications influen each other's effects
directly for example two medications
might both increase the blood pressure
producing a synergistic effect where the
blood pressure goes up even higher than
what you'd expect by simply adding the
two medication effects together likewise
a medication might work to increase
blood pressure by simply opposing the
effect of another medication thereby
having an antagonistic
effect all right as a quick recap each
medication is developed in three steps a
discovery preclinical and clinical step
and has three names a chemical generic
and brand name pharmacokinetics studies
what the body does to a medication and
pharmacodynamics studies what a
medication does to the body including
its beneficial and side effects
medications with a narrow therapeutic
index need to be closely monitored to
prevent toxicity drug interactions may
occur on both pharmacokinetic and
pharmacodynamic
levels
helping current and future clinicians
Focus learn retain and Thrive learn
more
Посмотреть больше похожих видео
Introduction to Drug Development & Regulation
Pharmacology - PHARMACOKINETICS (MADE EASY)
Lecture 1 | Pharmacology | Definitions of Pharmacology and its Branches | Pharmacy Technician
Pharmacokinetics part 1: Overview, Absorption and Bioavailability, Animation
Jalur Metabolisme dan Kerja Obat
Pharmacokinetics and Pharmacodynamics
5.0 / 5 (0 votes)